Core Insights - The approval of 2'-fucosyllactose for use in infant cereals and canned foods marks a significant advancement in China's infant food nutrition sector, aligning it with international research standards [1] - Akita Manman has launched the world's first organic formula rice flour containing HMO, addressing the core nutritional needs of Chinese infants during the weaning period [1][3] Industry Overview - Infant rice flour is considered the "first key meal" in baby food, with high consumer demands for nutrition, safety, and digestibility [2] - The infant food market in China exceeds hundreds of billions, with increasing consumer expectations for scientifically backed first foods [2] Product Highlights - The new organic formula rice flour features three core highlights: 1. The addition of HMO, which supports gut health and immunity in infants [4][5] 2. Collaboration with Kerry to create a more digestible product, incorporating A2β-casein and beneficial probiotics [6][7] 3. High iron content of 6.3mg/100g, combined with vitamin C to enhance absorption [8] Quality Control - Akita Manman implements a comprehensive quality control system from sourcing to production, ensuring organic standards and rigorous monitoring of pesticide residues [8] - The product utilizes a patented enzymatic process to achieve a smooth texture suitable for infants [8] Market Implications - The innovation signifies a shift from basic nutritional supplementation to functional precision feeding in the infant rice flour sector, potentially leading to technological advancements across the entire infant food industry [9]
秋田满满重磅推出全球首款HMO母乳低聚糖有机配方米粉
Nan Fang Du Shi Bao·2025-05-12 05:40